Satsuma Pharmaceuticals Stock Forecast - Daily Balance Of Power
STSADelisted Stock | USD 1.10 0.01 0.90% |
Satsuma Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Satsuma Pharmaceuticals stock prices and determine the direction of Satsuma Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Satsuma Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Satsuma |
Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
1.0 | 0.6667 |
Check Satsuma Pharmaceuticals Volatility | Backtest Satsuma Pharmaceuticals | Trend Details |
Satsuma Pharmaceuticals Trading Date Momentum
On June 07 2023 Satsuma Pharmaceuticals was traded for 1.10 at the closing time. The top price for the day was 1.14 and the lowest listed price was 1.01 . The trading volume for the day was 1.8 M. The trading history from June 7, 2023 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.90% . The trading price change against the current closing price is 0.00% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Satsuma Pharmaceuticals to competition
View Satsuma Pharmaceuticals Related Equities
Risk & Return | Correlation |
Satsuma Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Satsuma Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Satsuma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Satsuma Pharmaceuticals stock market strength indicators, traders can identify Satsuma Pharmaceuticals entry and exit signals to maximize returns.
Satsuma Pharmaceuticals Risk Indicators
The analysis of Satsuma Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Satsuma Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting satsuma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.39 | |||
Semi Deviation | 3.54 | |||
Standard Deviation | 8.57 | |||
Variance | 73.46 | |||
Downside Variance | 16.97 | |||
Semi Variance | 12.53 | |||
Expected Short fall | (4.82) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance |